Solriamfetol hydrochlorideProduct ingredient for Solriamfetol

Name: Solriamfetol hydrochloride
Drug Entry: Solriamfetol

Solriamfetol marketed under the brand name Sunosi by Jazz Pharmaceuticals in the United States is a dopamine and norepinephrine reuptake inhibitor (DNRI) indicated in treating daytime sleepiness associated with narcolepsy or obstructive sleep apnea^Label. Solriamfetol was given FDA approval in 2019^Label.

See full entry for Solriamfetol
Accession Number: DBSALT002865
Structure: MOL SDF PDB SMILES InChI
Structure for Solriamfetol hydrochloride (DBSALT002865)
Synonyms: Solriamfetol HCl / Solriamfetol hydrochloride